BMY - Bristol-Myers Squibb Company - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BMY is currently covered by 18 analysts with an average price target of $58.04. This is a potential upside of $11.29 (24.15%) from yesterday's end of day stock price of $46.75.

Bristol-Myers Squibb Company's activity chart (see below) currently has 193 price targets and 200 ratings on display. The stock rating distribution of BMY is 24.59% BUY, 60.66% HOLD and 14.75% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.44% with an average time for these price targets to be met of 669.77 days.

Highest price target for BMY is $73, Lowest price target is $39, average price target is $59.2.

Most recent stock forecast was given by AKASH TEWARI from JEFFERIES on 23-Apr-2025. First documented stock forecast 22-May-2013.

Currently out of the existing stock ratings of BMY, 15 are a BUY (24.59%), 37 are a HOLD (60.66%), 9 are a SELL (14.75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$68

$21.25 (45.45%)

26 days ago
(23-Apr-2025)

2/3 (66.67%)

$19.47 (40.12%)

18

Buy

27 days ago
(22-Apr-2025)

3/4 (75%)

$20.88 (37.88%)

652

Hold

$54

$7.25 (15.51%)

$43

1 months 8 days ago
(11-Apr-2025)

1/4 (25%)

$3.29 (6.49%)

12

Hold

$62

$15.25 (32.62%)

$52

3 months 12 days ago
(07-Feb-2025)

6/8 (75%)

$5.15 (9.06%)

48

Hold

$65

$18.25 (39.04%)

$60

3 months 21 days ago
(28-Jan-2025)

8/15 (53.33%)

$6.24 (10.62%)

1103

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BMY (Bristol-Myers Squibb Company) average time for price targets to be met?

On average it took 669.77 days on average for the stock forecasts to be realized with a an average price target met ratio 67.44

Which analyst has the current highest performing score on BMY (Bristol-Myers Squibb Company) with a proven track record?

CHRIS SCHOTT

Which analyst has the most public recommendations on BMY (Bristol-Myers Squibb Company)?

Chris Schott works at JPMORGAN and has 6 price targets and 6 ratings on BMY

Which analyst is the currently most bullish on BMY (Bristol-Myers Squibb Company)?

Chris Schott with highest potential upside - $33.25

Which analyst is the currently most reserved on BMY (Bristol-Myers Squibb Company)?

Terence Flynn with lowest potential downside - -$7.75

Bristol-Myers Squibb Company in the News

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

HONOLULU (AP) — Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general’s office announced Friday. A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a...

3 Healthcare Stocks in Hot Water

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns – over the past six months, healthcare stocks have collectively shed 13.3%. This drawdown was worse than the S&P 500’s 5.8%...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?